$2.19
0.052.34%
After Hours: 9:28 AM EDT
Comments
Loading...
MetaVia (NASDAQ:MTVA) Stock Quotes, Forecast and News Summary
MetaVia Stock (NASDAQ: MTVA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MetaVia (MTVA) stock?
You can purchase shares of MetaVia (NASDAQ:MTVA) through any online brokerage.
Who are MetaVia (MTVA) competitors?
Other companies in MetaVia’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Imunon (NASDAQ:IMNN) and Cellectar Biosciences (NASDAQ:CLRB).
What is the forecast, or price target, for MetaVia (MTVA) stock?
MetaVia has a consensus price target of $12.00.
What is the current price for MetaVia (MTVA)?
The stock price for MetaVia (NASDAQ: MTVA) is $2.5 last updated January 6, 2025 at 3:47 PM EST.
Does MetaVia (MTVA) pay a dividend?
There are no upcoming dividends for MetaVia.
When is MetaVia (NASDAQ:MTVA) reporting earnings?
MetaVia’s Q4 earnings are confirmed for Thursday, March 27, 2025.
Is MetaVia (MTVA) going to split?
There is no upcoming split for MetaVia.
What sector and industry does MetaVia (MTVA) operate in?
MetaVia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.